Literature DB >> 15149768

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.

Anna Gzyl1, Ewa Augustynowicz, Grzegorz Gniadek, Daniel Rabczenko, Grazyna Dulny, Janusz Slusarczyk.   

Abstract

The present study indicates that the appearance of the B. pertussis harbouring prn2 gene allele variant (not found among clinical isolates before 1990s) may have been induced by long-term vaccination in Poland with DTP-composed vaccine strains presenting exclusively prn1. However, ptxS1A allele of pertussis toxin subunit S1 encoding gene, predominant in the currently isolated B. pertussis strains, has been found in vaccine strains used for whole-cell pertussis component (wP) production of DTP vaccine in 1960-1978. This outrules the possibility that the appearance of ptxSIA allele might be related to vaccine pressure driven by non-ptxS1A vaccine strains used for long-term immunization with wP. Intranasal challenge animal model testing the efficiency of the clearance of B. pertussis strains harbouring different ptxS1/prn allele gene combinations revealed that currently produced DTwP vaccine may not contain adequate B. pertussis vaccine strains, since isolates with gene variants different from those observed in vaccine strains were eliminated from the lungs of the immunized animals with lower efficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149768     DOI: 10.1016/j.vaccine.2003.12.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Integrating life history and cross-immunity into the evolutionary dynamics of pathogens.

Authors:  Olivier Restif; Bryan T Grenfell
Journal:  Proc Biol Sci       Date:  2006-02-22       Impact factor: 5.349

3.  Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.

Authors:  Eiji Komatsu; Fuminori Yamaguchi; Akio Abe; Alison A Weiss; Mineo Watanabe
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

4.  Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.

Authors:  E Mosiej; M Zawadka; K Krysztopa-Grzybowska; M Polak; E Augustynowicz; K Piekarska; A Lutyńska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-05       Impact factor: 3.267

5.  Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.

Authors:  Daniela Bottero; María Emilia Gaillard; Matías Fingermann; Gabriela Weltman; Julieta Fernández; Federico Sisti; Augusto Graieb; Roy Roberts; Osvaldo Rico; Gustavo Ríos; Mabel Regueira; Norma Binsztein; Daniela Hozbor
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

6.  Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.

Authors:  Marcel Hijnen; Frits R Mooi; Pieter G M van Gageldonk; Peter Hoogerhout; Audrey J King; Guy A M Berbers
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

7.  Small mutations in Bordetella pertussis are associated with selective sweeps.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Frits R Mooi
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Comparative genomics of prevaccination and modern Bordetella pertussis strains.

Authors:  Marieke J Bart; Marjolein van Gent; Han G J van der Heide; Jos Boekhorst; Peter Hermans; Julian Parkhill; Frits R Mooi
Journal:  BMC Genomics       Date:  2010-11-11       Impact factor: 3.969

9.  Studies on Prn variation in the mouse model and comparison with epidemiological data.

Authors:  Marjolein van Gent; Inge H M van Loo; Kees J Heuvelman; Albert J de Neeling; Peter Teunis; Frits R Mooi
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

10.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.